Integrative profiling of multi-modal plasma cfRNA signatures enables detection and prognostic risk stratification in breast cancer.
Breast cancer requires non-invasive biomarkers for accurate detection and risk stratification. Collectively, multi-modal plasma cfRNA profiling may enable non-invasive breast cancer detection and provide candidate markers for prognostic risk stratification and future precision oncology applications.
Breast cancer requires non-invasive biomarkers for accurate detection and risk stratification. Collectively, multi-modal plasma cfRNA profiling may enable non-invasive breast cancer detection and provide candidate markers for prognostic risk stratification and future precision oncology applications.
What the study was
- Study design
- Diagnostic Validation Study
- Population
- Patient/participant population (size not extracted)
- Category
- Genomics/Precision Medicine
- Maturity
- Validated
- Journal
- Genomics
Why it surfaced
Scored 8/10 (Diagnostic Validation Study; novelty=2, relevance=3, design_quality=2, population_or_unmet_need=1). HIGH priority.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.